Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.

Zlobec I, Baker K, Minoo P, Hayashi S, Terracciano L, Lugli A.

Cancer. 2009 Sep 1;115(17):4021-9. doi: 10.1002/cncr.24450.

2.

Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging?

Cianchi F, Messerini L, Palomba A, Boddi V, Perigli G, Pucciani F, Bechi P, Cortesini C.

Dis Colon Rectum. 1997 Oct;40(10):1170-5; discussion 1175-6.

PMID:
9336111
3.

The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma.

Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, Martos JA, Moreno M.

Cancer. 1997 Jun 15;79(12):2320-8.

PMID:
9191519
4.

Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication.

Crispino P, De Toma G, Ciardi A, Bella A, Rivera M, Cavallaro G, Polistena A, Fornari F, Unim H, Pica R, Cassieri C, Mingazzini PL, Paoluzi P.

Cancer Invest. 2008 May;26(4):419-25. doi: 10.1080/07357900701788155.

PMID:
18443963
5.

Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.

Strzelczyk B, Szulc A, Rzepko R, Kitowska A, Skokowski J, Szutowicz A, Pawelczyk T.

Ann Surg Oncol. 2009 May;16(5):1287-94. doi: 10.1245/s10434-009-0381-0. Epub 2009 Mar 4.

PMID:
19259744
6.

Tumor budding as a prognostic marker in stage-III rectal carcinoma.

Choi HJ, Park KJ, Shin JS, Roh MS, Kwon HC, Lee HS.

Int J Colorectal Dis. 2007 Aug;22(8):863-8. Epub 2007 Jan 10.

PMID:
17216219
7.

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.

Zlobec I, Minoo P, Baumhoer D, Baker K, Terracciano L, Jass JR, Lugli A.

Cancer. 2008 Feb 1;112(3):495-502.

8.

Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.

Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B.

J Clin Oncol. 2009 Jan 10;27(2):186-92. doi: 10.1200/JCO.2008.18.7229. Epub 2008 Dec 8.

9.

Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer.

Huh JW, Lee JH, Kim HR.

Arch Surg. 2012 Apr;147(4):366-72. doi: 10.1001/archsurg.2012.35.

PMID:
22508783
10.

Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.

Prall F, Dührkop T, Weirich V, Ostwald C, Lenz P, Nizze H, Barten M.

Hum Pathol. 2004 Jul;35(7):808-16.

PMID:
15257543
11.

Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.

Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B; German Adrenocortical Carcinoma Registry Group; European Network for the Study of Adrenal Tumors.

Cancer. 2009 Jan 15;115(2):243-50. doi: 10.1002/cncr.24030.

12.

Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.

Jimi S, Hotokezaka M, Eto TA, Hidaka H, Maehara N, Chijiiwa K.

Hepatogastroenterology. 2008 May-Jun;55(84):926-9.

PMID:
18705299
13.

Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer.

Lo DS, Pollett A, Siu LL, Gallinger S, Burkes RL.

Cancer. 2008 Jan 1;112(1):50-4.

14.

[Study on independent factors on the prognosis of colorectal carcinoma: TNM stage, tumor budding, perineural invasion, peritumoral-lymphocytic infiltration and urine glucose].

Xu FY, Dong JK, Zhu YM, Qu MJ, Wang FJ, Jin YS, Ren GP, Lai MD.

Zhonghua Liu Xing Bing Xue Za Zhi. 2005 May;26(5):366-9. Chinese.

PMID:
16053766
15.

Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.

Gosens MJ, van Krieken JH, Marijnen CA, Meershoek-Klein Kranenbarg E, Putter H, Rutten HJ, Bujko K, van de Velde CJ, Nagtegaal ID; Cooperative Clinical Investigators and the Pathology Review Committee.

Clin Gastroenterol Hepatol. 2007 Aug;5(8):997-1003. Epub 2007 Jun 4.

PMID:
17544876
16.

Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.

Funada Y, Noguchi T, Kikuchi R, Takeno S, Uchida Y, Gabbert HE.

Oncol Rep. 2003 Mar-Apr;10(2):309-13.

PMID:
12579264
17.

Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.

Lugli A, Vlajnic T, Giger O, Karamitopoulou E, Patsouris ES, Peros G, Terracciano LM, Zlobec I.

Hum Pathol. 2011 Dec;42(12):1833-40. doi: 10.1016/j.humpath.2011.02.010. Epub 2011 Jun 12.

PMID:
21664647
18.

DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.

Buhmeida A, Hilska M, Elzagheid A, Laato M, Collan Y, Syrjänen K, Pyrhönen S.

Anticancer Res. 2009 Jan;29(1):99-106.

19.

Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.

Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.

Thorac Cardiovasc Surg. 2009 Oct;57(7):403-8. doi: 10.1055/s-0029-1185820. Epub 2009 Sep 30.

PMID:
19795327
20.

[Prognostic factors of colorectal carcinoma in the elderly after radical surgery].

Liang JW, Bai XF, Zhou ZX, Zhao DB, Wang CF, Zhao P.

Zhonghua Yi Xue Za Zhi. 2008 Jun 3;88(21):1467-70. Chinese.

PMID:
18953852
Items per page

Supplemental Content

Write to the Help Desk